Table 1.

Age- and gender-specific seroprevalence of HSV-1 and HSV-2 among rural residents in Eastern China

	Male (n = 1065)				Female (n = 1076)				Total (n = 2141)
			HSV-1	HSV-2			HSV-1	HSV-2			HSV-1	HSV-2
Age (years)	Tested/Eligible	%*	%** (95% CI)	%** (95% CI)	Tested/Eligible	%*	%** (95% CI)	%** (95% CI)	Tested/Eligible	%*	%** (95% CI)	%** (95% CI)
5-	75/106	70.8	59.8 (20.9-98.8)	0	40/54	74.1	64.9 (46.4-83.5)	0	115/160	71.9	61.6 (27.3-95.8)	0
10-	64/84	76.2	78.0 (47.6-100.0)	0	45/74	60.8	78.3 (37.8-100.0)	0	109/158	69.0	78.1 (75.2-81.1)	0
15-	89/109	81.7	76.5 (68.9-84.0)	5.4 (0-33.5)	78/97	80.4	87.5 (20.0-100.0)	8.9 (0-18.6)	167/206	81.1	81.6 (48.4-100.0)	7.1 (0-19.2)
20-	93/120	77.5	81.9 (43.2-100.0)	8.9 (0-64.1)	101/121	83.5	86.1 (64.5-100.0)	12.0 (0-48.7)	194/241	80.5	84.0 (78.0-90.0)	10.5 (0-54.5)
25-	112/134	83.6	86.5 (64.5-100.0)	5.3 (0-14.6)	135/155	87.1	93.3 (58.3-100.0)	13.3 (0-37.0)	247/289	85.5	90.3 (58.3-100.0)	9.7 (0-30.2)
30-	137/157	87.3	90.4 (72.2-100.0)	10.2 (2.4-18.0)	152/182	83.5	96.7 (94.7-100.0)	13.1 (5.0-21.3)	289/339	85.3	93.8 (82.3-100.0)	11.8 (11.5-12.0)
35-	144/163	88.3	93.7 (85.2-100.0)	13.8 (0-34.6)	154/182	84.6	95.5 (81.4-100.0)	16.2 (0-77.7)	298/345	86.4	94.6 (82.8-100.0)	15.1 (0-57.7)
40-	118129	91.5	97.4 (89.6-100.0)	13.6 (6.8-20.4)	129/153	84.3	98.4 (97.7-99.2)	17.8 (0-38.2)	247/282	87.6	98.0 (94.5-100.0)	15.9 (2.7-29.0)
45-	89/113	78.8	96.7 (60.5-100.0)	23.7 (0-100.0)	97/114	85.1	98.0 (76.9-100.0)	24.9 (0-60.5)	186/227	81.9	97.4 (68.7-100.0)	24.3 (0-84.8)
50-	82/106	77.4	98.7 (87.7-100.0)	8.5 (0-52.1)	101/120	84.2	98.1 (69.7-100.0)	16.1 (0-80.7)	183/226	81.0	98.4 (88.4-100.0)	12.5 (0.3-24.8)
55-	62/71	87.3	98.4 (76.2-100.0)	16.1 (4.7-37.0)	44/56	78.6	97.8 (71.8-100.0)	16.1 (0-63.0)	106/127	83.5	98.1 (97.1-99.1)	16.1 (7.1-25.2)
Total	1065/1292	82.4	89.1 (70.0-100.0)	10.5 (10.4-10.5)	1076/1308	82.3	94.2 (94.0-94.5)	15.3 (0-33.3)	2141/2600	82.3	92.0 (84.2-99.8)	13.2 (3.6-22.7)

*: participation rate; **: seroprevalence